Dr Venkat Shinde

Dr. Venkat Shinde PhD is a seasoned professional in the pharmaceutical and research support sectors, currently serving as the Chief Executive Officer at Veeprho Group since July 2011. Veeprho specializes in the isolation and purification of impurities via preparative HPLC and offers custom synthesis of complex molecules, with a global clientele that includes major pharmaceutical companies. Prior to this role, Dr. Shinde held key positions at Amneal Pharmaceuticals, Dr. Morepen NOW, and Piramal Enterprises Limited, focusing on analytical R&D for ANDA and DMF filings in the US market. Earlier experience includes significant contributions to Glenmark Pharmaceuticals and Wockhardt, where expertise in method development, validation, and compliance played crucial roles in advancing R&D initiatives.